Salute e Benessere

VIRBAC: MAR Weekly Report_VIRBAC SA_2 to 6 October 2023

Submission period02 to 06 OCT 2023 Submission Date06-Oct-2023 Issuer nameISIN CodeTransaction dateDaily total volume (in number of shares)Daily weighted average price of shares acquiredPlatform VIRBAC SAFR00000315772023.10.02183262.6011AQEUVIRBAC SAFR00000315772023.10.02317262.8328CEUXVIRBAC SAFR00000315772023.10.0226263.4615TQEXVIRBAC SA...
Nasdaq GlobeNewswire
09/10/2023

Over 1,100 exhibitors commit to attend 2024 China Association of Clinical…

In 2022, as reported by the China Association of In-Vitro Diagnostics (CAIVD), China's IVD market size reached USD 23.7 billion, up 30% year-on-year. This rapid growth signals the IVD industry's pivotal role in China's healthcare sector but also brings forth challenges and opportunities. In response to the increasing need for continuous innovation and adaptation, both Chinese and international IVD players fervently explore new development methods and strategies. In 2022, as reported by the...
PR Newswire
09/10/2023

AstronauTx closes £48 million ($61 million) Series A financing to create new…

AstronauTx was created by the Dementia Discovery Fund in 2019 with additional seed stage funding from the UCL Technology Fund and the UK Future Fund, with the goal of developing novel drugs to correct the disrupted physiology of the brain, partly through improving the support function of astrocytes, the most abundant cell type in the brain. AstronauTx was created by the Dementia Discovery Fund in 2019 with additional seed stage funding from the UCL Technology Fund and the UK Future Fund, with...
PR Newswire
09/10/2023

SANY Impresses at the Mining and Metals Central Asia & Kazcomak, Boosting…

As the earliest engineering machinery enterprise responding to China's Belt and Road Initiative (BRI), SANY established its Central Asia Business Unit in 2014, injecting high-quality products that have been since facilitating the region's infrastructure construction. As the earliest engineering machinery enterprise responding toChina'sBelt and Road Initiative (BRI), SANY established its Central Asia Business Unit in 2014, injecting high-quality products that have been since facilitating the...
PR Newswire
09/10/2023

Nanoflex Robotics Secures CHF 2.9M from Swiss Innovation Agency

The innovative medical robotic startup received CHF 2.9 million in non-dilutive grants in 2023Nanoflex Robotics and Brainomix to collaborate on AI-powered stroke interventions ZURICH, Switzerland, Oct.09, 2023(GLOBE NEWSWIRE) -- Nanoflex Robotics AG, a remote robotic surgical company based in Switzerland, announced it has received a second grant from Innosuisse, Switzerland's Innovation Agency this year.The receipt of the second grant brings Nanoflex Robotics' total...
Nasdaq GlobeNewswire
09/10/2023

Ultimovacs Receives FDA Orphan Drug Designation for the UV1 Cancer Vaccine for…

The orphan drug designation was granted based on data from the randomized Phase II clinical trial NIPU The results from the NIPU study will be presented at the ESMO Congress being held October 20-24, 2023 in MadridUV1 also received FDA orphan drug designation for treatment of patients with malignant melanoma in December 2021 Oslo, October 09, 2023:Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, today...
Nasdaq GlobeNewswire
09/10/2023

Stigmatisation a major impact of skin diseases across Europe, reveals JEADV…

88% patients with skin disease considered their disease to be embarrassing in their personal life, with 83% reporting the same in their working life. Furthermore, almost 25% reported to have changed their professional activity due to their disease, and work life was particularly impaired in patients with acne (48%) and urticaria (60%). 88% patients with skin disease considered their disease to be embarrassing in their personal life, with 83% reporting the same in their working life....
PR Newswire
09/10/2023

The Latest Fashion Source, Original Design Fashion Week & PV Shenzhen Mark a New…

The various activities were all curated to empower the fashion industry. FS Knitting Trends 2024-25AW was demonstrated by nearly 200 original knitted panels carefully selected by top designers and companies. When exploring this section, visitors could be inspired by seeing and touching the knitting pieces surrounded by trending colors, knitted garments, and installation artworks. For designers, product developers, and buyers who wanted to find fabrics and notions, the "FS U-Library"…
PR Newswire
08/10/2023

Smile Train makes History by Setting a GUINNESS WORLD RECORDS™ Title for Largest…

"This was truly a global effort, and what better place to celebrate! This honor is a win for the cleft community and all individuals born with a facial difference. At Smile Train, we're passionate about smiles because we know what a serious business they are. As an organization that supports free cleft surgeries and other comprehensive cleft care, this achievement reinforces the message that all smiles are beautiful," said Susannah Schaefer, President and CEO of Smile Train. "This…
PR Newswire
06/10/2023

Addex Announces Plan to Implement ADS Ratio Change

Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, October 6, 2023 - Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares (the “ADS Ratio”) from the current ADS Ratio of one (1) ADS to six (6) ordinary shares to a new ADS Ratio of one (1) ADS to one hundred...
Nasdaq GlobeNewswire
06/10/2023

Virbac : Half-yearly financial report 2023

Please find attached 2023 Half-yearly financial report of Virbac Attachment Half-Yearly Financial Report_2023
Nasdaq GlobeNewswire
06/10/2023

Virbac : Public release of the Half-Year Financial Report at 30 June 2023.

Public release of the Half-Year Financial Report at 30 June 2023.The Group released and filed its 2023 half-year financial report with the French “Autorité des marchés financiers”.The document is also available on the corporate website, at corporate.virbac.com, under “Investors”, “Financial Reports”.Attachment Public release of the Half-Year Financial Report_06.23
Nasdaq GlobeNewswire
06/10/2023

Ipsen - Monthly information relative to the total number of voting rights and…

Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1)30 September 202383,814,526Gross total* of...
Nasdaq GlobeNewswire
06/10/2023

Continuous Renal Replacement Therapy Market worth $2.1 billion |…

The rise in the global incidence of Acute kidney Injury (AKI) and increase in the demand for effective renal replacement therapy among the patients who are critically ill or in ICU and growing initiatives by the government to increase the awareness about CRRT therapy along with the increase in technologically advancement of the CRRT system are anticipated to fuel the CRRT market growth during the forecast period. The rise in the global incidence of Acute kidney Injury (AKI) and increase in…
PR Newswire
06/10/2023

Hearth Market size worth USD 11.69 Billion, Globally, by 2030 at 4.80% CAGR…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=5137 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=5137 Browse in-depth TOCon" Hearth Market " 202 - Pages 126 – Tables 37 – Figures Global Hearth Market Set to Soar: New Research Highlights Key Drivers and Market Outlook In a recent comprehensive market research report, industry experts have unveiled promising insights into the Hearth Market,...
PR Newswire
06/10/2023

Biosimilars Market size worth USD 109.2 Billion, Globally, by 2030 at 24.9%…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=8889 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=8889 Browse in-depth TOCon" Biosimilars Market " 202 - Pages 126 – Tables 37 – Figures Global Biosimilars Market Shows Robust Growth: Market Drivers and Emerging Opportunities Highlighted The global Biosimilars Market is witnessing significant growth, driven by a surge in demand for...
PR Newswire
06/10/2023

New Health Economic analysis in France concludes there is insignificant cost…

The most recent ccAFU (Comité de cancérologie de l'Association française d'urologie) guidelines recommend the use of BLC in a number of different positions in the care pathway for NMIBC. The study authors explain: "The health economic impact of this strategy has been evaluated using a cost-utility analysis, from the perspective of the French healthcare system, and was found to be dominant over WLC – meaning that its use results in better outcomes and lower costs overall. Despite the…
PR Newswire
06/10/2023

Olon, International API Supplier, Releases Its Annual Sustainability Report

Olon, international API supplier, is proud to publish its annual Corporate Sustainability Report, which details the global company commitment to people, planet, and communities in which it operates. The report outlines the substantial progresses achieved in the focus areas - to reduce the footprint on the environment, to create a sustainable global supply chain, to include people diversity, to engage communities and stakeholder, to promote the most advanced and sustainable manufacturing...
Nasdaq GlobeNewswire
06/10/2023

Optimum Strategic Communications to Host 15th Annual Healthcare Investor…

15 years of annual conferences have established the event as a prominent forum for the sector's largest investors and industry experts to discuss and debate their current thinking and vision for the Biotech & Healthcare sector. This year, there will be a special focus on Life Sciences in the UK, with the chance to hear from the country's leading investors and advisors, including Professor Sir Chris Whitty, Chief Medical Officer for England, who will be giving the Keynote. Panels will also…
PR Newswire
06/10/2023

UNION therapeutics announces presentation of new data on orismilast at the EADV…

Oral presentation detailsPresentation: A Phase 2a, open-label, single-center, single-arm, dose finding 16 weeks clinical trial of orismilast for the treatment of hidradenitis suppurativaPresenter: Prof., Dr. Gregor Jemec, Founding Chairman of the Department of Dermatology, Zealand University Hospital, DenmarkSession code: D2T01.3IDate and time: Thursday, October 12, 2023, at 16:30-16:45 CEST Oral presentation detailsPresentation: A Phase 2a, open-label, single-center, single-arm, dose...
PR Newswire
06/10/2023

Sequana Medical announces Extraordinary General Meeting of Shareholders on 10…

PRESS RELEASE REGULATED INFORMATION06 October 2023, 07:00 am CEST Ghent, Belgium – 06 October 2023– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Extraordinary General Meeting of Shareholders on Friday, 10 November 2023.The items on the agenda of the meeting include the...
Nasdaq GlobeNewswire
06/10/2023

Diffuse Cutaneous Systemic Sclerosis Market to Proliferate at a Considerable…

Key Takeaways from the Diffuse Cutaneous Systemic Sclerosis Market Report Key Takeaways from the Diffuse Cutaneous Systemic Sclerosis Market Report Discover which therapies are expected to grab the major diffuse cutaneous systemic sclerosis market share @Diffuse Cutaneous Systemic Sclerosis Market Report Diffuse Cutaneous Systemic Sclerosis Overview Diffuse cutaneous systemic sclerosis (dcSSc) is a medical condition characterized by widespread skin hardening and...
PR Newswire
05/10/2023

Alacrita Consulting Promotes Saadia Basharat & Jess Hearn-Messenger to…

In her new role, she will continue to advise clients on a range of strategic issues, including pipeline prioritization, disease area and indication prioritization, partnering strategy, and technical and commercial due diligence of therapeutics. In her new role, she will continue to advise clients on a range of strategic issues, including pipeline prioritization, disease area and indication prioritization, partnering strategy, and technical and commercial due diligence of therapeutics. ...
PR Newswire
05/10/2023

Monthly information regarding the total number of voting rights and total number…

Monthly information regarding the total number of voting rights andtotal number of shares of the Company as of September 30, 2023 (Article 223-16 of the General Regulations of theAutorité des Marchés Financiers )Market : NYSE Euronext ParisISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights09/30/2023 96,253,553 Total gross of voting rights: 96,253,553 Total net* of...
Nasdaq GlobeNewswire
05/10/2023
Altri  Comunicati